Connect with us

Technology

Coveo announces its intention to repurchase for cancellation 2,615,859 subordinate voting shares held by a subsidiary of Qatar Investment Authority

Published

on

MONTREAL, Sept. 22, 2026 /CNW/ — Coveo (“Coveo” or the “Company”) (TSX: CVO), the leader in AI-Relevance, delivering best-in-class search and generative experiences, today announced that it has entered into an agreement with Al-Rayyan Holding LLC (“Al-Rayyan”), a wholly-owned subsidiary of Qatar Investment Authority (“QIA”), to repurchase for cancellation 2,615,859 Subordinate Voting Shares of Coveo (“SVS”) held by Al-Rayyan (the “Repurchase”) immediately following the conversion by Al-Rayyan of an equivalent number of Multiple Voting Shares of Coveo (“MVS”), for a total repurchase price of approximately C$9,809,471. In addition, Al-Rayyan will pay Coveo a transaction fee.

The Repurchase will be completed at a price of $3.75 per SVS, which represents a discount of 10.5% on the closing price of the SVS on the Toronto Stock Exchange (“TSX”) on September 22, 2026. The purchase price will be paid using cash on hand.

In a separate concurrent transaction (the “Brokered Sale” and, together with the Repurchase, the “Transactions”), Al-Rayyan intends to dispose of an additional 4,800,000 SVS for aggregate consideration of $18,000,000, immediately following the conversion by Al-Rayyan of an equivalent number of MVS, through a separate prospectus-exempt bought deal block trade led by RBC Dominion Securities Inc. (“RBC”). In addition, Al-Rayyan will pay RBC a commission. Completion of the Repurchase is conditional upon completion of the Brokered Sale. Upon completion of the Transactions, Al-Rayyan will cease to hold any equity interest in Coveo.

The board of directors of Coveo (the “Board”) approved the Repurchase after considering, among other factors, the Company’s financial position and capital requirements and the terms of the Repurchase. The Board determined that the Repurchase represents an efficient use of excess capital, in addition to being immediately accretive to the Company’s shareholders. The Transactions also facilitate an orderly exit of Al-Rayyan’s investment in Coveo, and are expected to enhance trading liquidity by increasing the Company’s public float. The Repurchase demonstrates Coveo’s conviction in its business and the Board’s strong belief that Coveo’s SVS remain undervalued.

The Repurchase constitutes a “related party transaction” within the meaning of Regulation 61-101 Protection of Minority Security Holders in Special Transactions (“Regulation 61-101”) as Al-Rayyan is a “related party” of the Company within the meaning of Regulation 61-101. The Company is relying on the exemptions from the formal valuation and minority shareholder approval requirements under Regulation 61-101 on the basis that the fair market value of the SVS being repurchased and the consideration to be received by Al-Rayyan in respect of the Repurchase do not exceed 25% of the Company’s market capitalization determined in accordance with sections 5.5(a) and 5.7(1)(a) of Regulation 61-101, respectively. Closing of the Transactions is expected to occur on or before September 24, 2026, which is less than 21 days from the date hereof. Such shorter period is consistent with market practice and the Company believes is reasonable and necessary in the circumstances as it wishes to complete the Transactions in an expeditious manner.

Early Warning Disclosure

Prior to the Transactions, QIA, through Al-Rayyan, had beneficial ownership of, or control and direction over, 7,415,859 MVS, representing approximately 18.5% of the issued and outstanding MVS on an undiluted basis and approximately 16.4% of the aggregate voting rights associated with the issued and outstanding MVS and SVS. Immediately prior to the Transactions, QIA converted such MVS into 7,415,859 SVS, representing approximately 12.2% of the issued and outstanding SVS on an undiluted basis and approximately 1.9% of the aggregate voting rights associated with the issued and outstanding MVS and SVS. QIA has caused Al-Rayyan to undertake the Transactions to monetize QIA’s investment in Coveo.

This press release and QIA’s corresponding early warning report, which is expected to be filed on SEDAR+ in the near term, constitutes the required disclosure pursuant to pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.

QIA’s head office is located at Ooredoo Tower (Building 14), Al Dafna Street (Street 801), Al Dafna (Zone 61), Doha, Qatar. Al-Rayyan exists under the laws of Qatar. Coveo’s head office is located at 1100 Av. Des Canadiens-de-Montréal, Suite 401, Montréal, Quebec, Canada.

Forward-Looking Information

This press release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities laws, including statements relating to the Transactions (including with respect to the timing of settlement, completion and anticipated benefits thereof), and other statements that are not historical facts (collectively, “forward-looking information”). This forward-looking information is identified by the use of terms and phrases such as “may”, “would”, “should”, “could”, “might”, “will”, “achieve”, “occur”, “expect”, “intend”, “estimate”, “anticipate”, “plan”, “foresee”, “believe”, “continue”, “target”, “opportunity”, “strategy”, “scheduled”, “outlook”, “forecast”, “projection”, or “prospect”, the negative of these terms and similar terminology, including references to assumptions, although not all forward-looking information contains these terms and phrases. In addition, any statements that refer to expectations, intentions, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates, and projections regarding future events or circumstances.

Forward-looking information is necessarily based on a number of opinions, estimates, and assumptions that we considered appropriate and reasonable as of the date such statements are made. Although the forward-looking information contained herein is based upon what we believe are reasonable assumptions, actual results may vary from the forward-looking information contained herein. Forward-looking information is subject to known and unknown risks, uncertainties, and other factors, many of which are beyond our control, that may cause the actual results, level of activity, performance, or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to macro-economic uncertainties and the risk factors described under “Risk Factors” in the Company’s most recently filed Annual Information Form available under our profile on SEDAR+ at www.sedarplus.ca. There can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as of the date made. Moreover, we operate in a very competitive and rapidly changing environment. Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward- looking information, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information.

You should not rely on this forward-looking information, as actual outcomes and results may differ materially from those contemplated by this forward-looking information as a result of such risks and uncertainties. Except as required by law, we do not assume any obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

About Coveo

Coveo brings superior AI-Relevance to every point-of-experience, transforming how enterprises connect with their customers and employees to maximize business outcomes.

Relevance is about moving from person to person, the degree to which the enterprise-wide content, products, recommendations, and advice presented to a person online aligns easily with their context, needs, preferences, behavior and intent, setting the competitive experience gold standard. Every person’s journey is unique, and only AI can solve the complexity of tailoring experiences across massive, diverse audiences and large volumes and variety of content and products.

Stay up to date on the latest Coveo news and content by subscribing to the Coveo blog, and following Coveo on LinkedIn and YouTube.

SOURCE Coveo Solutions Inc.

Continue Reading

Technology

Chainguard Named a CVE Numbering Authority, Advancing Open Source Vulnerability Disclosure

Published

on

By

Authorization enables Chainguard to assign CVEs for qualifying open source vulnerabilities processed through Athena, helping protect open source software from AI attacks

NEW YORK, Sept. 22, 2026 /PRNewswire/ — Chainguard, the trusted source for open source, today announced that it has been authorized by the Common Vulnerabilities and Exposures (CVE®) Program as a CVE Numbering Authority (CNA). The mission of the CVE Program is to identify, define, and catalog publicly disclosed cybersecurity vulnerabilities. As a CNA, Chainguard can assign CVE identifiers and publish CVE Records for qualifying vulnerabilities. The authorization is scoped to include open source vulnerabilities processed through the Athena coalition, when upstream maintainers have already fixed the flaw without an identifier, no maintainer remains to assign one, or no more specific CNA covers the project.

This milestone underscores Chainguard’s deep commitment to transparent, coordinated vulnerability disclosure and protecting open source software from AI attacks. Frontier AI models are surfacing latent vulnerabilities in widely used open source software that traditional security tools and years of expert review failed to detect. As AI compresses the time between discovery and exploitation, vulnerabilities without CVE identifiers may remain invisible to the scanners, databases, and compliance systems organizations rely on to identify and prioritize risk.

“AI-driven zero-day discovery is pushing traditional approaches to vulnerability handling and disclosure to the breaking point,” said Quincy Castro, Chief Information Security Officer, Chainguard. “Through Athena, we are working to get fixes as quickly as possible into as many hands as possible. Becoming a CNA allows us to communicate about vulnerability fixes in a ‘language’ familiar to many organizations and open source maintainers.”

The designation strengthens Athena, Chainguard’s industry coalition for the orchestrated defense of open source software, by providing precise affected and fixed version ranges and technical details that help organizations assess their exposure, reduce false positives, and take appropriate action. Chainguard’s CVE Records also defer to maintainers and project-specific CNAs wherever they exist. With the help of coalition members and mitigation partners, such as Akamai, BNY, Cisco, Cloudflare, JPMorganChase, Kyndryl, Morgan Stanley, and Upwind, Athena validates AI-discovered vulnerabilities, and develops fixes, then partners with Akrites to carry vulnerabilities through disclosure and toward durable upstream remediation.

To learn more about how Chainguard advances open source vulnerability discovery through Athena, visit chainguard.dev/athena.

About Chainguard

Chainguard is the trusted source for open source. By providing engineers and AI agents with hardened, trusted, and production-ready artifacts, Chainguard helps organizations prevent AI supply chain attacks, increase engineering velocity while reducing toil, and maintain continuous compliance. Customers include Fortune 500 enterprises and global industry leaders, including Anduril, Canva, DocuSign, OpenAI, Public Storage, Snap Inc., and Snowflake. Chainguard is venture-backed by leading investors, including Amplify, IVP, Kleiner Perkins, Lightspeed Venture Partners, Mantis VC, Redpoint Ventures, Sequoia Capital, and Spark Capital.  For more information, visit: https://www.chainguard.dev/ 

Brittany Hendrickson, press@chainguard.dev 

View original content to download multimedia:https://www.prnewswire.com/news-releases/chainguard-named-a-cve-numbering-authority-advancing-open-source-vulnerability-disclosure-302886770.html

SOURCE Chainguard

Continue Reading

Technology

OxiWear and Alfardan Medical with Northwestern Medicine (AMNM) Announce Exclusive Distribution Partnership in Qatar

Published

on

By

Partnership marks an important step in OxiWear’s international expansion and growing presence in the Middle East

ARLINGTON, Va. and DOHA, Qatar, Sept. 22, 2026 /PRNewswire/ — OxiWear Inc., a wearable technology company focused on continuous physiological measurements, today announced an exclusive distribution partnership with Alfardan Medical with Northwestern Medicine (AMNM) in Qatar.

The partnership brings together OxiWear’s wearable measurement technology with AMNM’s established presence, local expertise, and network in Qatar, supporting OxiWear’s continued expansion across the Middle East.

The partnership marks another milestone in OxiWear’s international growth as the company continues to expand its technology and build strategic relationships across the United States and international markets.

“Qatar has built an incredible ecosystem around technology and innovation, and we are excited to partner with AMNM as we continue expanding OxiWear internationally,” said Shavini Fernando, Founder and CEO of OxiWear. “Having a strong local partner that understands the market and shares our long-term vision is incredibly important to us. We see significant opportunities for OxiWear in Qatar and across the region, and we look forward to working closely with Dr. Abdulla and the AMNM team to build that presence.”

Under the partnership, the organizations will collaborate on distribution, market development, customer engagement, and opportunities for OxiWear across Qatar.

“We are pleased to partner with OxiWear and support the company’s expansion into Qatar,” said Dr. Abdulla Al-Ansari, CEO of AMNM. “Innovation and the introduction of new technologies are important to the continued development of Qatar’s ecosystem. OxiWear’s approach to continuous physiological measurements presents exciting opportunities across a range of applications, and we look forward to working together to establish and grow its presence in Qatar.”

The partnership is part of OxiWear’s broader international expansion strategy and reflects the company’s focus on establishing strong local relationships as it enters and develops new markets.

About OxiWear: OxiWear Inc. is a wearable technology company developing solutions for continuous physiological measurements. Through its wearable technology and connected platform, OxiWear is building new ways to capture physiological data continuously across a range of environments and applications. Headquartered in Arlington, Virginia, OxiWear works with organizations and partners in the United States and internationally across research, performance, industrial, and other markets.

For more information, visit oxiwear.com.

Alfardan Medical with Northwestern Medicine (AMNM) is a multi-specialty private day-care surgery center located in Lusail, Qatar, operating in affiliation with Northwestern Medicine, the Chicago-based academic health system. AMNM brings together internationally trained physicians, advanced surgical facilities, and Northwestern Medicine’s clinical standards to deliver high-quality, patient-centered outpatient care across a wide range of specialties. Committed to innovation and clinical excellence, AMNM works to introduce new medical technologies and best practices that advance healthcare in Qatar and the wider region.

View original content to download multimedia:https://www.prnewswire.com/news-releases/oxiwear-and-alfardan-medical-with-northwestern-medicine-amnm-announce-exclusive-distribution-partnership-in-qatar-302886771.html

SOURCE OxiWear

Continue Reading

Technology

THE DOMINICAN REPUBLIC ANNOUNCES PRICING OF NEW NOTES OFFERING AND AGGREGATE PRINCIPAL AMOUNT OF TENDERS ACCEPTED FOR PURCHASE

Published

on

By

SANTO DOMINGO, Dominican Republic, Sept. 22, 2026 /PRNewswire/ — The Dominican Republic (the “Republic”) announced today the aggregate principal amount of bonds listed in the table below (the “Existing Bonds”) that has been validly tendered and accepted for purchase pursuant to its previously announced offer to purchase for cash the Existing Bonds (the “Offer”), pursuant to the terms and subject to the conditions described in the offer document dated September 15, 2026 (the “Offer Document”). The Offer expired as scheduled at 5:00 p.m. (New York City time) on September 21, 2026. Capitalized terms used but not defined herein have the meaning ascribed to them in the Offer Document.

Holders of Existing Bonds validly tendered and accepted for purchase by the Republic will receive US$1,006.25 per US$1,000 principal amount tendered (the “Purchase Price”) plus accrued and unpaid interest on such Existing Bonds up to, but excluding, the Settlement Date (as defined below) (“Accrued Interest”).

The Maximum Purchase Price for all Existing Bonds accepted for purchase is US$1,393,840,393.75. The Tendered Aggregate Purchase Price of the Existing Bonds validly tendered is US$1,393,840,393.75. Since the Tendered Aggregate Purchase Price does not exceed the Maximum Purchase Price, all Existing Bonds validly tendered pursuant to the Offer have been accepted for purchase, and, accordingly, there will be no proration.

The following table indicates the aggregate principal amount of Existing Bonds that have been validly tendered and accepted pursuant to the Offer.

Title of Existing Bonds

ISIN / CUSIP

Aggregate Principal Amount Tendered(1)

Aggregate Principal Amount of Tenders Accepted

Aggregate Principal Amount Remaining Outstanding

Purchase Price(2)

5.950% Bonds due
2027

USP3579EBV85 / P3579E BV8 (Reg S)

US25714PDT21 / 25714P DT2 (144A)

US$1,385,183,000

US$1,385,183,000

US$314,817,000

US$1,006.25

(1) Information regarding the aggregate principal amount of Existing Bonds tendered is based on information received from the Tender and Information Agent (as defined below).
(2) Per US$1,000 principal amount of the Existing Bonds validly tendered and accepted for purchase. Holders whose Existing Bonds were validly tendered and are accepted for purchase pursuant to the Offer will also receive Accrued Interest.

The Republic also announced the pricing of an offering of US$1,600,000,000 aggregate principal amount of 6.850% Bonds due 2039 (the “New Notes Offering”). The Offer is conditioned, among other things, on the concurrent (or earlier) closing of the New Notes Offering. The Republic intends to use a portion of the net proceeds from the New Notes Offering to purchase the Existing Bonds accepted for purchase. The New Notes Offering was made solely by means of an offering memorandum relating to the New Notes Offering, and neither this announcement nor the Offer Document constitutes an offer to sell or the solicitation of an offer to buy any such new bonds.

The settlement of validly tendered and accepted Existing Bonds is expected to occur on Monday, September 28, 2026, subject to change without notice (the “Settlement Date”). Holders of validly tendered and accepted Existing Bonds will be entitled to receive for such Existing Bonds the Purchase Price and Accrued Interest, which will be paid in U.S. dollars on the Settlement Date if the conditions of the Offer are met.

The Offer Document may be downloaded from the website of Global Bondholder Services Corporation (the “Tender and Information Agent”) at https://www.gbsc-usa.com/dominican/ or obtained from the Tender and Information Agent or from any of the Dealer Managers at the contact information below. Questions regarding the Offer may be directed to the Dealer Managers at the contact information below.

The Dealer Managers for the Offer are:

Citigroup Global Markets Inc.

388 Greenwich Street, 4th Floor Trading

New York, New York 10013

United States of America

Attn: Liability Management Group

Collect: +1 (212) 723-6106

Toll-Free: +1 (800) 558-3745

Email: ny.liabilitymanagement@citi.com

J.P. Morgan Securities LLC

270 Park Avenue

New York, New York 10017

United States of America

Attn: Latin America Debt Capital Markets

Collect: +1 (212) 834-7279

Toll-Free: +1 (866) 846-2874

The Tender and Information Agent for the Existing Bonds is:

Global Bondholder Services Corporation
65 Broadway – Suite 404
New York, New York 10006
United States of America
Attn: Corporate Actions
Banks and Brokers call: +1 (212) 430-3774
Toll free +1 (855) 654-2014
Email: contact@gbsc-usa.com
Offer Website: https://www.gbsc-usa.com/dominican/

By facsimile:
(For Eligible Institutions only):
+1 (212) 430-3775/3779

Confirmation:
+1 (212) 430-3774

By Mail:

By Overnight Courier:

By Hand:

65 Broadway – Suite 404

New York, New York 10006

United States of America

65 Broadway – Suite 404

New York, New York 10006

United States of America

65 Broadway – Suite 404

New York, New York 10006

United States of America

Important Notice

This announcement is for informational purposes only. It is not complete and may not contain all the information that you should consider before tendering Existing Bonds. You should read the entire Offer Document.

This announcement is not an offer to purchase for cash or a solicitation of invitations for offers to purchase for cash any Existing Bonds. The distribution of materials relating to the Offer and the transactions contemplated thereby may be restricted by law in certain jurisdictions. The Offer is being made only by the Offer Document and in those jurisdictions where it is legal to do so. The Offer is void in all jurisdictions where it is prohibited. If materials relating to the Offer come into your possession, you are required to inform yourself of and to observe all of these restrictions. Each person accepting the Offer shall be deemed to have represented, warranted and agreed (in respect of itself and any person for whom it is acting) that it is not a person to whom it is unlawful to make the Offer pursuant to the Offer Document, it has not distributed or forwarded the Offer Document or any other documents or materials relating to the Offer to any such person, and that it has complied with all laws and regulations applicable to it for purposes of participating in the Offer. Neither the Republic nor the Dealer Managers accepts any responsibility for any violation by any person of the restrictions applicable in any jurisdiction.

The materials relating to the Offer, including this announcement, do not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. This announcement and the Offer Document do not constitute an offer to buy or a solicitation of an offer to sell any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. In any jurisdiction in which the Offer is required to be made by a licensed broker or dealer and in which any Dealer Manager or any of its affiliates is so licensed, it shall be deemed to be made by the Dealer Managers or such affiliates on behalf of the Republic.

View original content:https://www.prnewswire.com/news-releases/the-dominican-republic-announces-pricing-of-new-notes-offering-and-aggregate-principal-amount-of-tenders-accepted-for-purchase-302886784.html

SOURCE The Dominican Republic

Continue Reading

Trending